Xingyao Long

Title: The Innovative Contributions of Xingyao Long

Introduction

Xingyao Long is a prominent inventor based in Chongqing, China. He has made significant strides in the field of microbiology, particularly in relation to inflammatory colon cancer. His work focuses on the application of specific microbial strains to improve health outcomes in cancer patients.

Latest Patents

Xingyao Long holds a patent for "Lacticaseibacillus rhamnosus AFY01 and application of product prepared from lacticaseibacillus rhamnosus AFY01 in inflammatory colon cancer." This patent, identified by the preservation number CGMCC No. 27362, details how AFY01 can effectively alleviate weight loss, intestinal inflammation, and edema induced colon shortening in mice with colon cancer. The findings suggest that AFY01 can reduce colon coefficient, visceral index, and the incidence of intestinal tumors in mice. Furthermore, it promotes apoptosis of intestinal tumor cells, thereby slowing down the development of colon cancer. This innovative strain expands bacterial resources and provides technical support for the prevention and treatment of colorectal cancer.

Career Highlights

Xingyao Long is affiliated with Chongqing University of Education, where he continues to advance research in microbiology and cancer treatment. His dedication to scientific inquiry has led to impactful discoveries that contribute to the understanding of microbial applications in health.

Collaborations

Xingyao Long collaborates with notable colleagues, including Xin Zhao and Fang Tan. Their combined expertise enhances the research efforts in their field, fostering innovation and discovery.

Conclusion

Xingyao Long's contributions to microbiology and cancer treatment exemplify the potential of innovative research in improving health outcomes. His work not only advances scientific knowledge but also offers hope for effective treatments in inflammatory colon cancer.